Phospho-MET-Y1349 Rabbit pAb
DA11; HGFR; AUTS9; RCCP2; c-Met; DFNB97
DA11; HGFR; AUTS9; RCCP2; c-Met; DFNB97
DA11; HGFR; AUTS9; RCCP2; c-Met; DFNB97
DA11; HGFR; AUTS9; RCCP2; c-Met; DFNB97
Glumetinib (SCC244) is a highly selective, orally bioavailable, ATP-competitive c-Met inhibitor with an IC50 of 0.42 nM. Glumetinib has greater than 2400-fold selectivity for c-Met over those 312 kinases evaluated, including the c-Met family member...